Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Fitoterapia ; 82(4): 642-6, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21316426

RESUMEN

A new diterpenoid, 15-angeloyloxy-16,17-epoxy-19-kauronic acid (1), along with five known metabolites, 16-kauren-19-oic acid (2), 6'-hydroxy-2',3',4,4'-tetramethoxychalcone (3), isosakuranetin (4), acacetin (5), and kaempferide (6) was isolated from the organic extracts of the roots of Chromoleana odorata. Their structures were determined by spectroscopic evidences. The structures of 1 and 2 were further confirmed by single-crystal X-ray diffraction studies. Compound 2 exhibited significant α-glucosidase inhibitory and antibacterial activities against Escherichia coli and Bacillus subtilis.


Asunto(s)
Antibacterianos/análisis , Chromolaena/química , Diterpenos de Tipo Kaurano/aislamiento & purificación , Inhibidores de Glicósido Hidrolasas , Diterpenos de Tipo Kaurano/química , Pruebas de Sensibilidad Microbiana , Raíces de Plantas/química , Difracción de Rayos X
2.
Chem Biodivers ; 5(1): 82-92, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18205128

RESUMEN

The synthesis, spectroscopic, enzyme-inhibition, and free-radical-scavenging properties of a series of vanadium(IV) complexes, compounds 1-10, were investigated. These complexes exhibit a dimeric structure with hydrazide ligands coordinated in a bidentate fashion. All complexes are stable in the solid state, but exhibit varying degrees of stability in solution. In coordinating solvent such as DMSO, stepwise binding of two solvent molecules at the 6th positions trans to the V double bond O bond of the dimeric unit is observed. The dimeric compounds are converted to monomeric species in which both solvent molecules and the hydrazide ligands are coordinated to the V(IV) center. The free hydrazide ligands 11-20 were inactive against alpha-glucosidase, but the V(IV) complexes showed varying degrees of inhibition, depending on the type of ligand. The DPPH-radical-scavenging activities of 1-20 were determined, which indicated that steric and/or electronic effects responsible for changes in geometry play important roles in terms of antioxidant potential.


Asunto(s)
Antioxidantes/química , Inhibidores Enzimáticos/química , Depuradores de Radicales Libres/química , Hidrazinas/química , Compuestos Organometálicos/química , Vanadio/química , Antioxidantes/síntesis química , Antioxidantes/farmacología , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacología , Depuradores de Radicales Libres/síntesis química , Depuradores de Radicales Libres/farmacología , Inhibidores de Glicósido Hidrolasas , Ligandos , Estructura Molecular , Compuestos Organometálicos/síntesis química , Compuestos Organometálicos/farmacología , Espectrofotometría Infrarroja/métodos , Espectrofotometría Ultravioleta/métodos , Estereoisomerismo
3.
Chem Biodivers ; 2(4): 487-96, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17191997

RESUMEN

A series of 2,4-diaryl-2,3,4,5-tetrahydro- (36-40) and 2,4-diaryl-2,3-dihydro-1,5-benzothiazepines (25-35) have been synthesized from the corresponding chalcones 1-24. Both the benzothiazepines and chalcones were evaluated as DPPH free-radical scavengers and as inhibitors of cholinesterases, urease, and alpha-glucosidase. Compounds 2, 5, 6, 7, 10, 13, 18, 21, 36a, 37a, 37b, and 39a showed significant cholinesterase inhibiting activities. Among the 15 dihydro-1,5-benzothiazepines, 26, 32, and 35 exhibited significant radical-scavenging activities; and six tetrahydro-1,5-benzothiazepines (35, 36a, 36b, 37a, 37b, and 39a) were found to be inhibitors of AChE and BChE. Compounds 22, 25, 26, 33, 35, 36a, 37b, and 39a inhibited urease, and 25 and 27-31 were found to be potent inhibitors of alpha-glucosidase.


Asunto(s)
Chalconas/química , Inhibidores de la Colinesterasa/química , Depuradores de Radicales Libres/química , Inhibidores de Glicósido Hidrolasas , Tiazepinas/química , Ureasa/antagonistas & inhibidores , Butirilcolinesterasa/metabolismo , Chalconas/farmacología , Estructura Molecular , Tiazepinas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA